Topical timolol 0.5% as the primary treatment of ophthalmic pyogenic granuloma: A prospective, single-arm study

PURPOSE: To study topical timolol (0.5%) as a first-line treatment in ophthalmic pyogenic granuloma (PG) in terms of safety and efficacy. METHODS: This was a prospective, interventional, single-arm study conducted at a tertiary eye care hospital in central India. Only new cases of PG were counseled...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaiswal, Hrishabh, Patidar, Narendra, Shah, Chintan, Singh, Rukmendra, Jain, Elesh, Piyush, Parimal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186631/
https://www.ncbi.nlm.nih.gov/pubmed/33913850
http://dx.doi.org/10.4103/ijo.IJO_2404_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186631/
https://www.ncbi.nlm.nih.gov/pubmed/33913850
http://dx.doi.org/10.4103/ijo.IJO_2404_20

Ejemplares similares